Export your current network:
... as a bitmap image:
file format is 'PNG': portable network graphic
... as a high-resolution bitmap:
same PNG format, but at higher resolution
... as a vector graphic:
SVG: scalable vector graphic - can be opened and edited in Illustrator, CorelDraw, Dia, etc
... as short tabular text output:
TSV: tab separated values - can be opened in Excel and Cytoscape (lists only one-way edges: A-B)
... as tabular text output:
TSV: tab separated values - can be opened in Excel (lists reciprocal edges: A-B,B-A)
... as an XML summary:
structured XML interaction data, according to the 'PSI-MI' data standard
... protein node degrees:
node degree of proteins in your network (given the current score cut-off)
... network coordinates:
a flat-file format describing the coordinates and colors of nodes in the network
... protein sequences:
MFA: multi-fasta format - containing the aminoacid sequences in the network
... protein annotations:
a tab-delimited file describing the names, domains and descriptions of proteins in your network
... functional annotations:
a tab-delimited file containing all known functional terms of protiens in your network
Browse interactions in tabular form:
node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
IFNG | PSME1 | ENSCDRP00005019497 | ENSCDRP00005022692 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Proteasome activator complex subunit 1. | 0.927 |
IFNG | PSME3 | ENSCDRP00005019497 | ENSCDRP00005014426 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Proteasome activator complex subunit 3. | 0.914 |
IFNG | TNF | ENSCDRP00005019497 | ENSCDRP00005029471 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Tumor necrosis factor. | 0.606 |
NR1H3 | PSME3 | ENSCDRP00005010144 | ENSCDRP00005014426 | Oxysterols receptor LXR-alpha. | Proteasome activator complex subunit 3. | 0.903 |
PSMA3 | PSMA5 | ENSCDRP00005005535 | ENSCDRP00005003685 | Proteasome subunit alpha type-3. | Proteasome subunit alpha type-5. | 0.998 |
PSMA3 | PSMA7 | ENSCDRP00005005535 | ENSCDRP00005006954 | Proteasome subunit alpha type-3. | Proteasome subunit alpha type-7. | 0.983 |
PSMA3 | PSMA8 | ENSCDRP00005005535 | ENSCDRP00005025047 | Proteasome subunit alpha type-3. | Proteasome subunit alpha type-7-like. | 0.982 |
PSMA3 | PSMB2 | ENSCDRP00005005535 | ENSCDRP00005031168 | Proteasome subunit alpha type-3. | Proteasome subunit beta type-2. | 0.999 |
PSMA3 | PSMB7 | ENSCDRP00005005535 | ENSCDRP00005009224 | Proteasome subunit alpha type-3. | Proteasome subunit beta type-7 isoform X1. | 0.990 |
PSMA3 | PSME1 | ENSCDRP00005005535 | ENSCDRP00005022692 | Proteasome subunit alpha type-3. | Proteasome activator complex subunit 1. | 0.986 |
PSMA3 | PSME3 | ENSCDRP00005005535 | ENSCDRP00005014426 | Proteasome subunit alpha type-3. | Proteasome activator complex subunit 3. | 0.824 |
PSMA5 | PSMA3 | ENSCDRP00005003685 | ENSCDRP00005005535 | Proteasome subunit alpha type-5. | Proteasome subunit alpha type-3. | 0.998 |
PSMA5 | PSMA7 | ENSCDRP00005003685 | ENSCDRP00005006954 | Proteasome subunit alpha type-5. | Proteasome subunit alpha type-7. | 0.998 |
PSMA5 | PSMA8 | ENSCDRP00005003685 | ENSCDRP00005025047 | Proteasome subunit alpha type-5. | Proteasome subunit alpha type-7-like. | 0.997 |
PSMA5 | PSMB2 | ENSCDRP00005003685 | ENSCDRP00005031168 | Proteasome subunit alpha type-5. | Proteasome subunit beta type-2. | 0.998 |
PSMA5 | PSMB7 | ENSCDRP00005003685 | ENSCDRP00005009224 | Proteasome subunit alpha type-5. | Proteasome subunit beta type-7 isoform X1. | 0.996 |
PSMA5 | PSME1 | ENSCDRP00005003685 | ENSCDRP00005022692 | Proteasome subunit alpha type-5. | Proteasome activator complex subunit 1. | 0.984 |
PSMA5 | PSME3 | ENSCDRP00005003685 | ENSCDRP00005014426 | Proteasome subunit alpha type-5. | Proteasome activator complex subunit 3. | 0.823 |
PSMA7 | PSMA3 | ENSCDRP00005006954 | ENSCDRP00005005535 | Proteasome subunit alpha type-7. | Proteasome subunit alpha type-3. | 0.983 |
PSMA7 | PSMA5 | ENSCDRP00005006954 | ENSCDRP00005003685 | Proteasome subunit alpha type-7. | Proteasome subunit alpha type-5. | 0.998 |
page 1 of 4